Pharmaceutical Sources

Latest News for: Pharmaceutical sources

Systech Asserts Leadership Position in Blockchain Solutions for the Pharmaceutical Supply Chain

Dothan Eagle 22 Aug 2018

PRINCETON, N.J., Aug ... We were honored to participate in this first of its kind, industry-wide collaborative study." ... About Systech.. Systech pioneered pharmaceutical serialization and is revolutionizing brand protection ... Contact ... Contact ... View original content. http.//www.prnewswire.com/news-releases/systech-asserts-leadership-position-in-blockchain-solutions-for-the-pharmaceutical-supply-chain-300700392.html. SOURCE Systech International . ....

Edit

$50 Billion Vaccines Market by Technology, Disease, Route, Patient, Type - Global Forecast to 2023 ...

Ellensburg Daily Record 22 Aug 2018

DUBLIN--(BUSINESS WIRE)--Aug 21, 2018--The "Vaccines Market by Technology, Disease, Route, Patient, Type - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering ... On the other hand, market growth may be hindered due to the high cost of vaccine development ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180821005633/en/ ... HEALTH INFECTIOUS DISEASES PHARMACEUTICAL. SOURCE ... PUB....

Edit

2018 Global Healthcare Licensing - Trends: By Industry (Pharmaceuticals) Mid-Year Review - ResearchAndMarkets.com

Waco Tribune-Herald 21 Aug 2018

By Industry (Pharmaceuticals) Mid-Year Review" report has been added to ResearchAndMarkets.com's offering ... Such detailed analysis helps to understand the licensing trends and directions during this time period in the global pharmaceuticals sector ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180821005445/en/ ... HEALTH PHARMACEUTICAL. SOURCE....

Edit

Citron Pushes Down CV Sciences. Does It Make Sense?

Seeking Alpha 21 Aug 2018

The market needs to calm down and study the company's revenue sources closely ... The company is separated into two business segments; consumer products and specialty pharmaceutical ... Source ... The specialty pharmaceutical business segment is focused on developing synthetic cannabinoids to treat wide range of medical conditions ... Source ... Source ... Source ... Source ... Source ... Source ... Source ... Source ... Source ... Source ... Source ... Source ... Source ... Source ... Source....

Edit

Santhera to Report First Half-Year Financial Figures and Provide Corporate Update on September 4, 2018

Post-Bulletin 21 Aug 2018

Santhera Pharmaceuticals Holding AG / Santhera to Report First Half-Year Financial Figures and Provide Corporate Update on September 4, 2018 ... Pratteln, Switzerland, August�21, 2018 - Santhera Pharmaceuticals (SIX.�SANN) will announce its first half-year financial figures for 2018 and provide a corporate update on Tuesday, September�4, 2018, at 07.00 CEST / 06.00 BST / 01.00 EDT ... Source....

Edit

NeuroVive Pharmaceutical AB Interim Report January - June 2018

Market Watch 21 Aug 2018

This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation ... Erik Kinnman CEO +46(0)46-275-62-20 ir@neurovive.comNeuroVive Pharmaceutical AB (publ) Medicon Village SE-223 81 Lund Sweden Tel ... http.//news.cision.com/neurovive-pharmaceutical/r/neurovive-pharmaceutical-ab-interim-report-january---june-2018,c2596516 ... SOURCE NeuroVive Pharmaceutical....

Edit

OWC Pharmaceutical Research Corp Announced Personnel Changes

Market Watch 21 Aug 2018

21, 2018 /PRNewswire/ -- OWC Pharmaceutical Research Corp ... About OWC Pharmaceutical Research Corp ... Mordechai Bignitz , Chief Executive Officer – OWC Pharmaceutical research crop, ... View original content with multimedia.http.//www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-announced-personnel-changes-300700156.html. SOURCE OWC Pharmaceutical Research Corp....

Edit

Global Potassium Citrate Market to Grow at a CAGR of 3.3% During 2018-2024 - ResearchAndMarkets.com

Odessa American 21 Aug 2018

DUBLIN--(BUSINESS WIRE)--Aug 21, 2018--The "Potassium Citrate Market. Global Industry Analysis, Trends, Market Size and Forecasts up to 2024" report has been added to ResearchAndMarkets.com's offering ... Key Topics Covered. 1. Preface. 1.1 ... 1.2 ... 2 ... Pharmaceuticals Grade ... Pharmaceutical ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180821005464/en/ ... HEALTH PHARMACEUTICAL MANUFACTURING CHEMICALS/PLASTICS. SOURCE....

Edit

HIV/Aids Patient Groups Perspective of Corporate Reputation of Pharma Companies, 2017-2018: Patient Groups are Still ...

Odessa American 21 Aug 2018

The 2017 Corporate-Reputation survey found HIV/AIDS patient groups to be especially critical of the progress that the pharmaceutical industry may (or may not) have made on a whole set of issues, including. ... Two main themes arising out of HIV/AIDS patient-group comments to the 2017 Corporate-Reputation survey is the wish for pharmaceutical companies to. ... Related Topics.Pharmaceuticals ... HEALTH AIDS PHARMACEUTICAL. SOURCE....

Edit

Imago BioSciences Completes Enrollment in Phase 1/2a Study of IMG-7289 in Acute Myeloid Leukemia and ...

Odessa American 21 Aug 2018

SAN CARLOS, Calif.--(BUSINESS WIRE)--Aug 21, 2018--Imago BioSciences, a clinical-stage pharmaceutical company developing novel anti-cancer therapies, announced today that the Phase 1/2a clinical trial of IMG-7289 for the treatment of high-risk acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS) has fully enrolled at 45 patients ... HEALTH BIOTECHNOLOGY CLINICAL TRIALS ONCOLOGY PHARMACEUTICAL. SOURCE....

Edit

Allegro Ophthalmics Prepares To Take Lead Compound Risuteganib To Phase 3, Appoints New CEO

Waco Tribune-Herald 21 Aug 2018

Karageozian has more than 25 years’ experience building, leading, and raising capital for companies in the ophthalmic pharmaceutical space ... Karageozian is the co-founder of three ophthalmic biotech companies, including ISTA Pharmaceuticals, Inc., Vitreoretinal Technologies, Inc., and Allegro ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20180821005059/en/ ... SOURCE....

Edit

MC2 Therapeutics Announces Positive Top-line Results from Phase 3 Clinical Trial Comparing MC2-01 Cream to ...

Odessa American 21 Aug 2018

COPENHAGEN, Denmark--(BUSINESS WIRE)--Aug 21, 2018--MC2 Therapeutics A/S, an emerging pharmaceutical company developing next generation patient-friendly topical therapies for skin and eye diseases, today announced the following top-line data from its US Phase 3 study (n=796) on the company’s investigational drug, MC2-01 Cream (calcipotriene and betamethasone dipropionate, w/w 0.005%/0.064%). ... SOURCE....

Edit

Recombinetics Closes $34 Million in Series A Funding

Odessa American 21 Aug 2018

Acceligen (precision breeding to enhance health, well-being and productivity in food animals and aquaculture); Surrogen (gene-edited swine models of human diseases for biomedical research and pre-clinical trials by pharmaceutical and medical device companies); and Regenevida (development of human regenerative products including cells, tissues and organ products in swine models for exotransplantation to humans) ... SOURCE....

Edit